SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-24-000134
Filing Date
2024-01-24
Accepted
2024-01-24 13:33:08
Documents
3

Document Format Files

Seq Description Document Type Size
1 POS AM lxrp_posam.htm POS AM 167338
2 CONSENT lxrp_ex231.htm EX-23.1 2512
3 CONSENT lxrp_ex232.htm EX-23.2 2685
  Complete submission text file 0001640334-24-000134.txt   173713
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: POS AM | Act: 33 | File No.: 333-271096 | Film No.: 24555574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)